Industry News

Kraig Biocraft Laboratories Takes Next Step in Launching Spydasil Apparel Brand
  • Kraig Biocraft Laboratories, Inc., the biotechnology company focused on the development and commercialization of spider silk, announces that, in collaboration with its joint venture partner Kings Group, the Company has selected a high-quality garment manufacturer to produce Spydasilk’s first apparel line.

  • Throughout multiple meetings between Kraig Labs, Kings Group, and the garment manufacturer, conducted while the Company’s COO was in Vietnam this month, the Company finalized its manufacturer choice for the first apparel launch under the Spydasilk brand.

  • The manufacturer selected has demonstrated its capacity and technical ability to deliver on Spydasilk’s vision for apparel that blends performance and elegance with its exclusive spider silk materials. With more than 20 years in business and its strong ties to Vietnam’s entire textile supply chain, this producer can leverage the capabilities of the best mills to bring the Spydailk brand to life.
In partnership with Kings Group, the Company has already delivered its recombinant spider silk yarn and a non-spider silk fabric swatch for use in developing a brand new fabric built upon the performance and feel of the Company’s spider silk. “Bringing the first products built on our spider silk technology to life is a critical step we are taking simultaneously with our planned increase in production through third-party contractors,” said Company COO, Jon Rice. “The network we have assembled to launch Spydasilk brings together top textile science, fashion, marketing, and branding experts. Our vision for the mass production and distribution of products built upon the amazing capabilities of spider silk is now quickly becoming a reality.” About Kraig Biocraft Laboratories, Inc.Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully reporting biotechnology company, is a developer of genetically engineered spider silk-based fiber technologies.
subscribe to the needle's eye newsletter
Copyright © 2022 NeedlesEye.net by The Gardner Group, Inc.

We use cookies to enable essential functionality on our website, and analyze website traffic. By clicking Accept you consent to our use of cookies. Read about how we use cookies.

Your Cookie Settings

We use cookies to enable essential functionality on our website, and analyze website traffic. Read about how we use cookies.

Cookie Categories

Essential

These cookies are strictly necessary to provide you with services available through our websites. You cannot refuse these cookies without impacting how our websites function. You can block or delete them by changing your browser settings, as described under the heading "Managing cookies" in the Privacy and Cookies Policy.

Analytics

These cookies collect information that is used in aggregate form to help us understand how our websites are being used or how effective our marketing campaigns are.